High-dose vitamin C management in dapsone-induced methemoglobinemia.

Am J Emerg Med

Department of Emergency Medicine, Catholic University of Daegu School of Medicine, Daegu, Republic of Korea.

Published: June 2014

Methylene blue is the first-choice treatment of methemoglobinemia, but it is not readily available in most Korean emergency departments because of an import suspension. An 84-year-old woman with dapsone-induced massive methemoglobinemia visited our emergency department for unclear mentality and cyanosis. Because methylene blue was not available, we intravenously administrated vitamin C (VC) for symptomatic methemoglobinemia, although VC is not a universally accepted treatment. Vitamin C (10 g intravenously) administered 6 hourly successfully treated the dapsone-induced methemoglobinemia and did not adversely affect renal functions. Thus,we recommend that if methylene blue is unavailable, 6 hourly intravenous administrations of 10 g of VC should be considered for dapsone-induced methemoglobinemia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajem.2013.11.036DOI Listing

Publication Analysis

Top Keywords

dapsone-induced methemoglobinemia
12
methylene blue
12
methemoglobinemia
6
high-dose vitamin
4
vitamin management
4
dapsone-induced
4
management dapsone-induced
4
methemoglobinemia methylene
4
blue first-choice
4
first-choice treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!